Literature DB >> 17501911

Expression of Thy 1.2 surface antigen increases significantly during the murine mesenchymal stem cells cultivation period.

Mohamadreza Baghaban Eslaminejad1, Samad Nadri, Reza Hajji Hosseini.   

Abstract

This study sought to investigate the absence or expression of some surface antigens on murine mesenchymal stem cells (mMSCs) during the cultivation period of primary culture to passage 3 (equivalent to about 15 or 16 population doubling number). For this purpose, bone marrow cells from 6-8-week-old mice (either NMRI or Balb/c) were cultivated in 75-cm(2) culture flask for three successive passages, in each of which the culture was examined for the expression of CD135, CD44, CD31, Thy1.2, CD11b, CD45, CD34, Vcam1, Sca-1, and c-Kit antigens, using flow cytometry. Passage-3 cells from each strain can easily be differentiated into bone and fat, which was indicative of their mesenchymal nature. Our results demonstrated that for each given antigen, the percentages of the cells expressing that antigen had been changed by subcultures. The statistical analysis showed that nearly all differences between the passages were statistically significant. In this term, the expressional changes of Thy 1.2 seemed to be very significant in such a way that the expression increased to about half of the whole population in passage 3. In conclusion, it seems that this antigen could be considered as an enriching antigen for mMSCs population from bone marrow adherent cell culture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17501911     DOI: 10.1111/j.1440-169X.2007.00932.x

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  8 in total

1.  The effect of topography on differentiation fates of matrigel-coated mouse embryonic stem cells cultured on PLGA nanofibrous scaffolds.

Authors:  Mohammad Massumi; Mozhgan Abasi; Hamideh Babaloo; Panieh Terraf; Mojtaba Safi; Mahdi Saeed; Jalal Barzin; Mojgan Zandi; Masoud Soleimani
Journal:  Tissue Eng Part A       Date:  2011-12-14       Impact factor: 3.845

2.  Characterization of progenitor cells in pulps of murine incisors.

Authors:  A Balic; M Mina
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

3.  Molecular characterization of prospectively isolated multipotent mesenchymal progenitors provides new insight into the cellular identity of mesenchymal stem cells in mouse bone marrow.

Authors:  Hong Qian; Aurora Badaloni; Francesca Chiara; Jenny Stjernberg; Naresh Polisetti; Kristian Nihlberg; G Giacomo Consalez; Mikael Sigvardsson
Journal:  Mol Cell Biol       Date:  2012-11-26       Impact factor: 4.272

Review 4.  Mesenchymal stem cells for treatment of aortic aneurysms.

Authors:  Aika Yamawaki-Ogata; Ryotaro Hashizume; Xian-Ming Fu; Akihiko Usui; Yuji Narita
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

5.  Characterization of stem and progenitor cells in the dental pulp of erupted and unerupted murine molars.

Authors:  Anamaria Balic; H Leonardo Aguila; Melissa J Caimano; Victor P Francone; Mina Mina
Journal:  Bone       Date:  2010-02-26       Impact factor: 4.398

6.  Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein.

Authors:  Hong Qian; Katarina Le Blanc; Mikael Sigvardsson
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

7.  Murine mesenchymal stem cell isolated and expanded in low and high density culture system: surface antigen expression and osteogenic culture mineralization.

Authors:  Mohamadreza Baghaban Eslaminejad; Samad Nadri
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-05-19       Impact factor: 2.416

8.  Isolation of High Purity Mouse Mesenchymal Stem Cells through Depleting Macrophages Using Liposomal Clodronate.

Authors:  Ju Han Song; Jung-Woo Kim; Mi Nam Lee; Sin-Hye Oh; Xianyu Piao; Zhao Wang; Seung-Hee Kwon; Ok-Su Kim; Jeong-Tae Koh
Journal:  Tissue Eng Regen Med       Date:  2022-01-01       Impact factor: 4.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.